文献
J-GLOBAL ID:201702276021121838
整理番号:17A1718197
新興市場における評価オフ特許医薬品(OPPs)のための根拠に基づくHTA方法論としての多基準意思決定解析(MCDA)簡単なスコアリングの適用【Powered by NICT】
Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets
著者 (9件):
Brixner Diana
(Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA)
,
Brixner Diana
(Pharmacotherapy Outcomes Research Center, Salt Lake City, UT, USA)
,
Maniadakis Nikos
(Health Services Organization and Management, National School of Public Health, Athens, Greece)
,
Kalo Zoltan
(Institute of Economics, Eotvos Lorand University (ELTE), Budapest, Hungary)
,
Kalo Zoltan
(Syreon Research Institute, Budapest, Hungary)
,
Hu Shanlian
(School of Public Health, Fudan University, Shanghai, China)
,
Hu Shanlian
(Shanghai Health Development and Research Center, Shanghai, China)
,
Shen Jie
(Abbott Established Pharmaceutical Division, Basel, Switzerland)
,
Wijaya Kalman
(Abbott Established Pharmaceutical Division, Basel, Switzerland)
資料名:
Value in Health Regional Issues
(Value in Health Regional Issues)
巻:
13
ページ:
1-6
発行年:
2017年
JST資料番号:
W2930A
ISSN:
2212-1099
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)